Humira

3 Big Biotech Stocks With Big-Time Catalysts
Motley Fool
Sun, 04/9/17 - 12:36 pm
Regeneron
Praluent
Amgen
biosimilars
Amjevita
Humira
ABP-215
Avastin
ABP-980
Herceptin
Celgene
ozanimod
$5B in Humira sales at stake with Amgen EU approval
BioPharma Dive
Sat, 03/25/17 - 12:18 pm
Humira
Amgen
Europe
rheumatoid arthritis
Amgevita
biosimiliars
The 19 Best-Selling Prescription Drugs of All-Time
Motley Fool
Mon, 03/13/17 - 11:29 am
Lipitor
Humira
Seretide
Remicade
Plavix
Enbrel
Rituxan
Herceptin
Avastin
Nexium
Zyprexa
Pfizer says rheumatoid arthritis drug is comparable to Humira as combination treatment but not alone
Marketwatch
Thu, 02/16/17 - 03:13 pm
Pfizer
Xeljanz
AbbVie
Humira
rheumatoid arthritis
Amgen Gets EU Nod for Humira Biosimilar
Investopedia
Mon, 01/30/17 - 10:54 pm
Amgen
Humira
biosimilars
ABP 501
Boehringer Ingelheim's Humira Biosimilar Under Review by EMA, FDA
Yahoo/GuruFocus
Fri, 01/20/17 - 09:45 am
Boehringer Ingelheim
Humira
biosimilars
FDA
EMA
BI 695501
AbbVie
3 Biggest Risks for AbbVie in 2017
Motley Fool
Wed, 12/28/16 - 11:03 am
AbbVie
Humira
biosimilars
Imbruvica
Viekira Pak
Elagolix
risankizumab
As Humira readies for biosimilar rivals, AbbVie looks to ASH to build oncology momentum
Fierce Pharma
Sat, 12/3/16 - 09:21 am
Humira
AbbVie
biosimilars
ASH
AbbVie's Humira a Step Closer to Approval in Europe
Yahoo/GuruFocus
Wed, 11/16/16 - 09:50 am
AbbVie
Humira
Europe
J&J, GSK stumble coming out of the gate with mixed PhIII rheumatoid arthritis data for sirukumab
Endpoints
Sun, 11/13/16 - 12:00 pm
JNJ
GSK
rheumatoid arthritis
sirukumab
AbbVie
Humira
AbbVie: Take That Coherus!
Barron's
Tue, 11/8/16 - 09:58 am
AbbVie
Coherus Biosciences
Humira
biosimilars
In October TV pharma ad spending, AbbVie's Humira and Pfizer's Lyrica continue to dominate
Fierce Pharma
Mon, 11/7/16 - 09:40 am
drug ads
AbbVie
Humira
Pfizer
Lyrica
3 Things AbbVie's Management Said While Its Stock Got Hammered
Motley Fool
Sat, 10/29/16 - 01:23 pm
AbbVie
earnings
Humira
Imbruvica
Viekira Pak
FDA approval could be delayed for Sanofi Genzyme’s next blockbuster
Bizjournals.com
Fri, 10/28/16 - 10:19 am
FDA
Sanofi
Sanofi Genzyme
drug manufacturing
biosimilars
Humira
Sarilumab
Boehringer flags PhIII success for another Humira knockoff, setting up a crowded field of cheaper rivals — eventually
Endpoints
Wed, 10/26/16 - 09:16 pm
Boehringer Ingelheim
Humira
BI 695501
AbbVie
rheumatoid arthritis
AbbVie Is Under Duress With Fierce Competition
Seeking Alpha
Thu, 10/20/16 - 09:20 am
AbbVie
Humira
biosimilars
Amgen
Baxalta
Shire
Could J&J's recent news about its rheumatoid arthritis and Crohn's disease drugs threaten AbbVie's Humira?
Motley Fool
Thu, 10/13/16 - 11:18 am
JNJ
rheumatoid arthritis
Crohn's Disease
AbbVie
Humira
sirukumab
J&J psoriasis drug tops placebo, Humira in late stage study
Yahoo/Reuters
Mon, 10/3/16 - 09:42 pm
JNJ
psoriasis
Humira
AbbVie
guselkumab
FDA Approval of Amjevita Need Not Worry AbbVie Shareholders
Yahoo/GuruFocus
Thu, 09/29/16 - 08:14 am
FDA
AbbVie
Amgen
biosimilars
Humira
Amjevita
Shire punts late-stage biosimilars of Humira and Enbrel back to Momenta, Coherus
Endpoints
Wed, 09/28/16 - 10:18 am
Shire
biosimilars
Humira
Enbrel
Momenta

Pages